11 research outputs found
Serum EPO and VEGF levels in patients with sleep-disordered breathing and acute myocardial infarction
Increased risk of minor bleeding and antiplatelet therapy cessation in patients with acute coronary syndromes and low on-aspirin platelet reactivity. A prospective cohort study
Presence and severity of obstructive sleep apnea and remote outcomes of atrial fibrillation ablations — a long-term prospective, cross-sectional cohort study
Direct, Label-Free, and Rapid Transistor-Based Immunodetection in Whole Serum
Transistor-based
biosensors fulfill many requirements posed upon
transducers for future point-of-care diagnostic devices such as scalable
fabrication and label-free and real-time quantification of chemical
and biological species with high sensitivity. However, the short Debye
screening length in physiological samples (<1 nm) has been a major
drawback so far, preventing direct measurements in serum. In this
work, we demonstrate how tailoring the sensing surface with short
specific biological receptors and a polymer polyethylene glycol (PEG)
can strongly enhance the sensor response. In addition, the sensor
performance can be dramatically improved if the measurements are performed
at elevated temperatures (37 °C instead of 21 °C). With
this novel approach, highly sensitive and selective detection of a
representative immunosensing parameterhuman thyroid-stimulating
hormoneis shown over a wide measuring range with subpicomolar
detection limits in whole serum. To the best of our knowledge, this
is the first demonstration of direct immunodetection in whole serum
using transistor-based biosensors, without the need for sample pretreatment,
labeling, or washing steps. The presented sensor is low-cost, can
be easily integrated into portable diagnostics devices, and offers
a competitive performance compared to state-of-the-art central laboratory
analyzers
Label-Free Immunodetection in High Ionic Strength Solutions Using Carbon Nanotube Transistors with Nanobody Receptors
Nanomaterial-based field-effect transistors (FETs) have been proposed for real-time, label-free detection of various biological species. However, screening of the analyte charge by electrolyte ions (Debye screening) has so far limited their use in physiological samples. Here, this challenge is overcome by combining FETs based on single-walled semiconducting carbon nanotube networks (SWCNTs) with a novel surface functionalization comprising: (1) short nanobody receptors, and (2) a polyethylene glycol layer (PEG). Nanobodies are stable, easy-to-produce, short biological receptors (~2–4 nm) that enable analyte binding closer to the sensor surface. The addition of PEG enhances the signal in high ionic strength environment. Using green fluorescent protein (GFP) as a model antigen, high selectivity and sub-picomolar detection limit with a dynamic range exceeding 4 orders of magnitude is demonstrated in physiological solutions. The presented immunoassay is fast, label-free, does not require any sample pre-treatment or washing steps